Obesity is no longer just a personal issue
Obesity is increasingly being recognized not as a matter of personal choice or lifestyle, but as one of the greatest public health challenges of modern society. In addition to its impact on individual health, obesity places a growing burden on healthcare systems, affects work capacity and quality of life, and has significant social and economic consequences. This is why modern obesity management relies on a long-term, individualized, and multidisciplinary approach. In line with this approach, Galenika introduced Olire®, a GLP-1 therapy indicated for the treatment of obesity and excess body weight, to the Serbian market. As part of a comprehensive approach, the company has also developed the Oli-support line of food supplements, designed to provide nutritional support for people working toward weight loss.
Obesity affects much more than the individual
The number of people living with obesity continues to rise in almost every part of the world, prompting experts to warn that the consequences extend far beyond individual health. Obesity is associated with an increased risk of numerous chronic diseases, including type 2 diabetes, cardiovascular disease, and certain types of cancer. It can also affect everyday functioning, productivity, and overall quality of life. Increasing attention is also being paid to its impact on healthcare systems, the labor market, and broader societal costs, making prevention and treatment a growing public health priority.
Why the approach to obesity treatment is changing
Modern medicine recognizes obesity as a chronic and complex disease influenced by genetics, hormones, metabolism, psychological factors, and lifestyle habits. For this reason, long-term results rarely depend solely on willpower or discipline, but rather on an approach that combines medical therapy when indicated, lifestyle modification, healthy nutrition, regular physical activity, and appropriate nutritional support.
Nutritional support as part of a comprehensive approach
Based on this concept, Galenika developed the Oli-support line of food supplements, designed to provide nutritional support for people working toward weight loss. The products in this line may be used alongside Olire® or other GLP-1 therapies as part of a comprehensive approach, in accordance with the advice of a healthcare professional.
For some individuals, lifestyle changes or GLP-1 therapy may be accompanied by digestive discomfort that can affect everyday well-being. That is why the Oli-support line also includes Oli-Nex, a food supplement containing ginger and licorice extracts. Ginger supports normal digestion and helps prevent nausea and vomiting, while together with licorice it contributes to digestive health, overall physical well-being, energy, and vitality.
A shared responsibility for long-term outcomes
Obesity is no longer just an individual’s personal challenge—it is a public health issue that requires the coordinated efforts of healthcare professionals, institutions, employers, and individuals themselves. Guided by this understanding of modern obesity management, Galenika introduced Olire®, a GLP-1 therapy indicated for the treatment of obesity and excess body weight, and developed the Oli-support line of food supplements to provide nutritional support for people working toward weight loss.
The combination of medical therapy when indicated, healthy nutrition, regular physical activity, and appropriate nutritional support forms part of a comprehensive approach aimed at achieving sustainable results and improving quality of life.
This article was originally published on eKapija: https://www.ekapija.com/news/5597202/gojaznost-vise-nije-samo-licni-problem